Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS‐PC study

We previously conducted a phase I clinical trial combining the HLA‐A*2402‐restricted KIF20A‐derived peptide vaccine with gemcitabine for advanced pancreatic cancer (PC) and confirmed its safety and immunogenicity in cancer patients. In this study, we conducted a multicenter, single‐armed, phase II t...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Sci
Main Authors: Suzuki, Nobuaki, Hazama, Shoichi, Iguchi, Haruo, Uesugi, Kazuhiro, Tanaka, Hiroaki, Hirakawa, Kosei, Aruga, Atsushi, Hatori, Takashi, Ishizaki, Hidenobu, Umeda, Yuzo, Fujiwara, Toshiyoshi, Ikemoto, Tetsuya, Shimada, Mitsuo, Yoshimatsu, Kazuhiko, Shimizu, Ryoichi, Hayashi, Hiroto, Sakata, Koichiro, Takenouchi, Hiroko, Matsui, Hiroto, Shindo, Yoshitaro, Iida, Michihisa, Koki, Yasunobu, Arima, Hideki, Furukawa, Hiroyuki, Ueno, Tomio, Yoshino, Shigefumi, Nakamura, Yusuke, Oka, Masaaki, Nagano, Hiroaki
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2016
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5276830/
https://ncbi.nlm.nih.gov/pubmed/27783849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13113
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki